跳至主要内容
临床试验/CTRI/2014/09/005070
CTRI/2014/09/005070已完成未知

Intravitreal Bevacizumab Versus Triamcinolone for Treatment of Diabetic Macular Edema-- One Year Results

ethradhama Superspeciality Eye Hospita0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All Patients with clinically significant macular oedema (according to ETDRS study) with systemic diabetis mellitus of > 3 months duration.
  • Patients were required to have a baseline CRT of at least 300 um and BCVA of 20/25 to 20/400 Snellen equivalent in the study eye.
  • Patients with HbA1c controlled at less than 8.0% at the beginning and during the study duration.

排除标准

  • Patients with bilateral macular oedema, with retinal thickness difference between two eyes of >100um.
  • Patient with history of
  • Macular Laser Photocoagulation
  • Intravitreal Injection Therapy
  • Active Proliferative Diabetic Retinopathy (PDRP) With Necessity Of Panretinal Laser Treatment
  • Panretinal Laser Treatment Within The Past 3 Months
  • Previous vitreous surgery
  • IHD & CVA

研究者

发起方
ethradhama Superspeciality Eye Hospita

相似试验